CASC15 is involved in the manipulation of biological processes in various diseases, which could be a new potential biological therapeutic target [14], as its abnormal down-expression has been found in ovarian cancer, glioma, and neuroblastoma [15]. This evidence concerns the gene CASC15 and ovarian cancer.